Return to Home Incidence > Table

Incidence Rates Table

Data Options
Comparison Options

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, Ages 50+

Sorted by Percentlate

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 64.3 (64.1, 64.5) N/A 75,131 59.3
Puerto Rico 2 14.5 (14.0, 14.9) N/A 754 49.1
District of Columbia 2 55.4 (50.7, 60.5) 45 (29, 51) 103 53.1
Alabama 2 63.4 (61.8, 65.1) 28 (22, 34) 1,174 53.7
California 7 55.4 (54.8, 56.0) 46 (42, 48) 7,131 54.6
New Mexico 7 53.3 (51.0, 55.7) 48 (43, 51) 419 55.4
Connecticut 7 55.0 (53.2, 56.8) 47 (41, 49) 761 55.5
New York 7 59.4 (58.6, 60.2) 39 (33, 42) 4,350 56.3
Vermont 2 52.1 (48.1, 56.2) 49 (41, 51) 138 56.5
Iowa 7 67.3 (65.2, 69.5) 20 (13, 26) 784 56.6
Massachusetts 2 51.5 (50.3, 52.8) 50 (47, 51) 1,320 56.6
Nevada 2 60.0 (57.9, 62.2) 35 (29, 43) 642 56.7
Hawaii 7 62.5 (59.5, 65.5) 31 (20, 42) 355 56.9
Minnesota 2 60.8 (59.3, 62.4) 33 (28, 41) 1,210 56.9
Louisiana 7 75.4 (73.4, 77.3) 5 (3, 10) 1,206 57.1
Kentucky 7 78.8 (76.8, 80.8) 3 (2, 6) 1,270 57.3
New Jersey 7 66.1 (64.8, 67.3) 23 (18, 27) 2,222 57.3
Nebraska 2 66.0 (63.2, 68.9) 22 (13, 32) 439 57.5
Maine 2 59.1 (56.3, 62.0) 40 (28, 47) 352 57.9
Oklahoma 2 70.0 (68.0, 72.0) 13 (8, 21) 941 58.1
Georgia 7 69.1 (67.9, 70.4) 15 (11, 21) 2,387 58.6
Arizona 2 55.8 (54.5, 57.1) 44 (41, 48) 1,484 59.1
Utah 7 49.9 (47.7, 52.2) 51 (48, 51) 403 59.6
Florida 2 64.2 (63.4, 64.9) 27 (22, 30) 5,854 59.7
Virginia 2 59.5 (58.3, 60.8) 38 (32, 42) 1,770 59.7
Arkansas 2 76.2 (73.9, 78.6) 4 (3, 9) 831 60.0
Maryland 2 61.7 (60.2, 63.2) 32 (27, 39) 1,332 60.1
North Dakota 2 68.5 (64.0, 73.3) 17 (5, 32) 178 60.1
Texas 7 69.0 (68.2, 69.8) 16 (12, 20) 5,915 60.1
Michigan 2 63.1 (61.9, 64.2) 29 (24, 33) 2,368 60.4
Delaware 2 59.9 (56.5, 63.5) 36 (23, 47) 236 60.6
Oregon 2 57.7 (56.0, 59.5) 42 (35, 46) 888 60.7
Kansas 2 71.5 (69.1, 73.9) 11 (5, 19) 719 61.0
Ohio 2 69.8 (68.7, 70.9) 14 (10, 19) 3,049 61.0
New Hampshire 2 60.3 (57.4, 63.4) 34 (24, 44) 335 61.1
Washington 1 59.9 (58.5, 61.2) 37 (31, 42) 1,534 61.1
West Virginia 2 81.4 (78.5, 84.4) 2 (1, 4) 605 61.1
Illinois 7 72.2 (71.0, 73.3) 10 (7, 14) 3,214 61.3
Wisconsin 2 62.4 (60.9, 64.0) 30 (24, 37) 1,357 61.3
Rhode Island 2 58.5 (55.2, 61.9) 41 (28, 48) 242 61.4
Alaska 2 75.2 (69.7, 81.0) 6 (2, 20) 158 61.5
Montana 2 66.6 (63.0, 70.2) 21 (9, 33) 280 61.5
Idaho 7 64.6 (61.8, 67.6) 25 (16, 35) 402 61.7
Mississippi 2 86.2 (83.7, 88.8) 1 (1, 2) 904 61.7
South Carolina 2 65.1 (63.5, 66.8) 24 (19, 30) 1,260 61.9
Indiana 2 73.0 (71.5, 74.6) 9 (5, 13) 1,718 62.0
Pennsylvania 2 68.5 (67.5, 69.5) 18 (13, 21) 3,496 62.1
Tennessee 2 71.4 (69.9, 72.9) 12 (7, 16) 1,751 62.1
North Carolina 2 64.6 (63.5, 65.8) 26 (20, 30) 2,393 62.3
Colorado 2 56.5 (54.9, 58.1) 43 (39, 48) 1,038 62.4
Missouri 2 74.6 (72.9, 76.2) 7 (4, 11) 1,678 62.6
Wyoming 2 68.1 (63.0, 73.4) 19 (5, 35) 140 62.8
South Dakota 2 73.2 (69.0, 77.7) 8 (3, 21) 233 62.9

Notes:
Created by statecancerprofiles.cancer.gov on 03/22/2026 11:15 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.

Return to Top